Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 5351-5360 of 12129

Page
per page
  1. NX-2127
    BA8820 NX-2127
    Summary: NX-2127 is an orally effective inhibitor that induces the degradation of mutations in cells.
  2. H-Leu-Gly-OH
    BA9386 H-Leu-Gly-OH
    Summary: A glycine derivative.
  3. Fatostatin
    A9954 Fatostatin
    Summary: A specific inhibitor of SREBP
      ≥25.35 mg/mL
  4. Cy7 NHS ester (non-sulfonated)
    A8104 Cy7 NHS ester (non-sulfonated)
     1 Citation
    Summary: Labeling of amino-groups in biomolecules.
      ≥34.1 mg/mL
  5. Barnidipine (hydrochloride)
    C3727 Barnidipine (hydrochloride)
    Summary: calcium-channel blocker
      insoluble in H2O; insoluble in EtOH; ≥16.3 mg/mL
  6. VU590 (hydrochloride)
    C4778 VU590 (hydrochloride)
    Summary: inhibitor of KCNJ1
      ≤20 mg/mL
  7. FR122047 (hydrate)
    C5551 FR122047 (hydrate)
    Summary: selective inhibitor of COX-1
      ≤1 mg/mL
  8. Coumestrol
    C5832 Coumestrol
     1 Citation
    Summary: competitive binder of the estrogen receptors ERα
      ≥12.35 mg/mL
  9. Besifloxacin HCl
    B1895 Besifloxacin HCl
    Summary: fourth-generation fluoroquinolone antibiotic
      insoluble in EtOH; insoluble in DMSO; ≥4.3 mg/mL
  10. Acarbose sulfate
    B1276 Acarbose sulfate
    Summary: Inhibitor of alpha glucosidase
      Soluble in DMSO

Items 5351-5360 of 12129

Page
per page